SML3621

Erlotinib

≥98% (HPLC), EGFR tyrosine kinase inhibitor, powder

• Synonym(s): 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline, 6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]- (3-ethynyl-phenyl)amine, Erlotinib free base, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, NSC 718781, OSI-774
• Empirical Formula (Hill Notation): C₂₂H₂₃N₃O₄
• CAS Number: 183321-74-6
• Molecular Weight: 393.44
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD02089651
• Assay: ≥98% (HPLC)
• Form: powder

Properties

• Product Name: Erlotinib, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: -10 to -25°C
• SMILES string: N(c3cc(ccc3)C#C)c1ncnc2c1cc(c(c2)OCCOC)OCCOC
• InChI key: AAKJLRGGTJKAMG-UHFFFAOYSA-N

Description

Biochem/physiol Actions

Erlotinib is an orally available, potent, and specific inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase. Erlotinib binds to the ATP binding site of the receptor. It is used to treat lung and pancreatic cancer.

orally available, potent, and specific inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase

Safety Information

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• pcodes: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• Storage Class: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable